Amicus Therapeutics

Signaling a major shift at the FDA, regulators put Amicus’ once-spurned drug on fast track
Signaling a major shift at the FDA, regulators put Amicus’ once-spurned drug on fast track
Endpoints
FDA
Amicus Therapeutics
migalastat
Fabry disease
fast track
Flag link:
FDA Reverses Decision, Allowing Amicus To File For Rare Disease Drug
FDA Reverses Decision, Allowing Amicus To File For Rare Disease Drug
Forbes
FDA
Amicus Therapeutics
Rare Diseases
Fabry disease
migalastat
Flag link:
Are These 2 Biotechs Diamonds in the Rough?
Are These 2 Biotechs Diamonds in the Rough?
Motley Fool
biotech
Amicus Therapeutics
Adamas Pharmaceuticals
ADS-5102
Galafold
Flag link:
Biotechs Breaking Out On Drug Development News
Biotechs Breaking Out On Drug Development News
Forbes
Bluebird Bio
Esperion Therapeutics
Amicus Therapeutics
Kite Pharma
Flag link:
Four biotech stocks surging on optimism about drug trials, product launches
Four biotech stocks surging on optimism about drug trials, product launches
Marketwatch
clinical trials
Bluebird Bio
Amicus Therapeutics
Kite Pharma
NeuroDerm
Flag link:
4 Biopharma Stocks Moving the Market on Wednesday
4 Biopharma Stocks Moving the Market on Wednesday
Yahoo/24-7 Wall St
Skyline Medical
Dynavax Technologies
Amicus Therapeutics
Pacira
Flag link:
These Small Biotechs Are Poised to Go Higher
These Small Biotechs Are Poised to Go Higher
Investopedia
biotech
Blood Therapeutics
Versartis
Amicus Therapeutics
Flag link:
Key FDA Decision And Trial Dates In February
Key FDA Decision And Trial Dates In February
Seeking Alpha
FDA
Amgen
Valeant Pharmaceuticals
Amphastar
Egalet
Lexicon Pharmaceuticals
Amicus Therapeutics
Axovant
Flag link:
FDA Requests Additional Data on Amicus’ Fabry Disease Treatment
FDA Requests Additional Data on Amicus’ Fabry Disease Treatment
Yahoo/24-7 Wall St
Fabry disease
FDA
Amicus Therapeutics
Flag link:
5 Small-Cap Biotechs With Big Potential
5 Small-Cap Biotechs With Big Potential
TheStreet.com
biotech
Portola Pharmaceuticals
Progenics
Redhill Biopharma
Dynavax
Amicus Therapeutics
Flag link:
Amicus' Fabry disease drug gets European Commission approval
Amicus' Fabry disease drug gets European Commission approval
Yahoo/Reuters
Amicus Therapeutics
Fabry's disease
Europe
migalastat
Flag link:
Amicus, Other Biotech CEOs Should Listen More, Talk Less About FDA Matters
Amicus, Other Biotech CEOs Should Listen More, Talk Less About FDA Matters
TheStreet.com
Amicus Therapeutics
FDA
Flag link:
Amicus Acquires Scioderm, Adds Drug for Rare Skin Disorder to Pipeline
Amicus Acquires Scioderm, Adds Drug for Rare Skin Disorder to Pipeline
TheStreet.com
Amicus Therapeutics
Scioderm
M&A
Flag link:
5 Drugs That Investors May Be Undervaluing
5 Drugs That Investors May Be Undervaluing
Motley Fool
Amicus Therapeutics
Galafold
Receptos
ozanimod
GS-5816
Gilead Sciences
ACH-3102
Achillion
Ophthotech
Fovista
Flag link:
Amicus Jumps to Seven-Year High After $225 Million Share Sale
Amicus Jumps to Seven-Year High After $225 Million Share Sale
Bloomberg
Amicus Therapeutics
Flag link:
Biotech Investors Guide and Preview to the J.P. Morgan Healthcare Conference Part 1
Biotech Investors Guide and Preview to the J.P. Morgan Healthcare Conference Part 1
TheStreet.com
Celgene
Gilead Sciences
Express Scripts
Biogen Idec
Amicus Therapeutics
NPS Pharmaceuticals
Sanofi
Acadia
Orexigen
Pharmacyclics
Vertex Pharmaceuticals
Flag link:
3 Biotech Stocks We're Watching Closest Ahead of the JPMorgan Healthcare Conference
3 Biotech Stocks We're Watching Closest Ahead of the JPMorgan Healthcare Conference
Motley Fool
Celgene
Intercept Pharmaceuticals
Amicus Therapeutics
Flag link:
The Best-Performing Biotechnology Stocks Of 2014
The Best-Performing Biotechnology Stocks Of 2014
Forbes
biotech
Avanir
OvaScience
Agios
Bluebird Bio
Receptos
Prosensa
Pernix
Achillion
Amicus Therapeutics
CytoSorbents
PTC Therapeutics
Flag link:
These 4 Biotech Stocks Have Been On Fire
These 4 Biotech Stocks Have Been On Fire
Yahoo/Benzinga
Agios Pharmaceuticals
Achillion
Amicus Therapeutics
Orexigen
Flag link:
Drug Slowed Progression Of Parkinson's Disease, In New Study
Drug Slowed Progression Of Parkinson's Disease, In New Study
Forbes
Parkinson's Disease
Amicus Therapeutics
AT2101
Flag link: